Ledger.Open graph →
SEC Form D · filed August 14, 2025

KAZIA THERAPEUTICS LTD

Offering
$2.1M
Sold
$2.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SYDNEY NSW, Channel Islands
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Bryce Carmine · Sydney, Channel IslandsDirectorRobert Apple · Sydney, Channel IslandsDirectorElissa Hansen · Sydney, Channel IslandsExecElissa Hansen · Sydney, Channel IslandsExecJeffrey Bonacorda · Sydney, Channel IslandsExecEbru Davidson · Sydney, Channel IslandsDirectorJeff G. Runnfeldt · New York, NYExecEbru Davidson · Sydney, Channel IslandsDirectorTodd G. Rapp · New York, NYDirectorChad Terry · Osceola, IADirectorCraig Stilwell · Osceola, IAExecSteven Coffey · Sydney, Channel IslandsDirectorJohn Friend · Sydney, Channel IslandsExecJeffrey Bonacorda · Sydney, Channel IslandsExecRobert Apple · Sydney, Channel IslandsDirectorRobert Taylor · Osceola, IAExecChristina Taylor · Osceola, IADirectorSteven Coffey · Sydney, Channel IslandsDirectorBryce Carmine · Sydney, Channel IslandsDirectorJames Ruggerio · Chatham, NJDirectorJohn Friend · Sydney, Channel IslandsExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗